Does tocilizumab prevent relapse in patients with giant cell arteritis?
Treatment with tocilizumab, an interleukin (IL)-6 receptor antagonist, is effective for corticosteroid sparing in patients with giant cell arteritis (GCA), suggests a study. However, tocilizumab allows for a prolonged remission in fewer than half of the patients following treatment discontinuation.
